MIRA Pharmaceuticals, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MIRA Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2026-03-31 was $86.00K, a 2443.02% increase year-over-year.
- MIRA Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2025-06-30 was $323.84K.
- MIRA Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2025-03-31 was $3.38K.
- MIRA Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2024-12-31 was $478.93K.
- MIRA Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2025 was $6.71M, a 86.07% increase from fiscal 2024.
- MIRA Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2024 was $3.61M.
- MIRA Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2022 was $2.90M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-03-31 | $86.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $6.71M 10-K · filed 2026-03-31 | |
| 2025-06-30 | $323.84K 10-Q · filed 2025-11-13 | $3.94M derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | $3.38K 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $478.93K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.61M 10-K · filed 2026-03-31 |
| 2024-09-30 | $3.13M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-08-16 | |
| 2023-03-31 | $147.80K 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $2.90M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $900.00K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $1.58M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |